You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Evidence of treatment benefit: is seeing believing or obfuscation by statistics?

Multiple Sclerosis Journal

Impact Factor: 5.0 / 5-Year Impact Factor: 5.2

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online November, 2009

Evidence of treatment benefit: is seeing believing or obfuscation by statistics?

Volume 15, Issue 11

https://doi.org/10.1177/1352458509350169

Abstract

Get full access to this article

View all access options for this article.

References

Veugelers PJ , Fisk JD , Brown MG , et al. Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: A longitudinal population-based evaluation. Mult Scler 2009 ; 15: 1286-1294.

Weinshenker BG , Bass B. , Rice GPA , et al. The natural history of multiple sclerosis: A geographically based study. Brain 1991; 114: 1057-1067.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials – NO

Retricted access

Clinical course of multiple sclerosis: A nationwide cohort study

Retricted access

A Parallel-Group Comparison of Budesonide and Beclomethasone Dipropionate for the Treatment of Perennial Allergic Rhinitis in Adults

Retricted access

Methylprednisolone treatment in multiple sclerosis: effect of treatment,pharmacokinetics,future